· Discuss structures, motivations and best practices for patient engagement, introducing a three-way perspective across oncology and rare disease
· Examine experience to date at MPNE within oncology, directions for the future, possible framework for action
· Engage with a examples of patient engagement & communication in a rare disease US Expanded Access Program
A discussion from multiple stakeholder perspectives on what’s currently happening in various therapeutic areas with all the attention current being focused on COVID-19. Focus topics will include the conduct of trials, investment into new research, patient engagement and regulatory pathways.
The central question to be asked will be: How do we justify what we are doing under – and with - Covid in comparison to what we are doing for other diseases?